Industry Developments

Following in the footsteps of drug developers that are recognising the attraction of emerging markets as a base for clinical trials, Inventiv Health, a leading provider of clinical... 2008-03-14

Following in the footsteps of drug developers that are recognising the attraction of emerging markets as a base for clinical trials, Inventiv Health, a leading provider of clinical... 2008-03-14

Following in the footsteps of drug developers that are recognising the attraction of emerging markets as a base for clinical trials, Inventiv Health, a leading provider of clinical... 2008-03-14

Flat funding at the National Institutes of Health (NIH) is damaging the biomedical research sector, claims a recent report, entitled 'Broken Pipeline', presented to the US Senate... 2008-03-12

Baxter's heparin production problems appear to have given a boost to APP Pharmaceuticals, which had been expecting a tough year after it parted company with its biotech interests... 2008-03-11

Demonstrating the innovative strength of Cuba's biotech industry, researchers at the Marine Bioproducts Center (Cebimar) are advancing the development of two drugs derived from the... 2008-03-11

Demonstrating the innovative strength of Cuba's biotech industry, researchers at the Marine Bioproducts Center (Cebimar) are advancing the development of two drugs derived from the... 2008-03-11

Demonstrating the innovative strength of Cuba's biotech industry, researchers at the Marine Bioproducts Center (Cebimar) are advancing the development of two drugs derived from the... 2008-03-11

Demonstrating the innovative strength of Cuba's biotech industry, researchers at the Marine Bioproducts Center (Cebimar) are advancing the development of two drugs derived from the... 2008-03-11

Shares in German drug giant Bayer have fallen after a US district court ruled that the patent on its blockbuster oral contraceptive Yasmin (drospirenone and ethinyl estradiol) is... 2008-03-10